SEP-363856
SEP-363856 is an orally and CNS-active psychotropic agent with a novel, non-D2/5-HT2A mechanism, demonstrating antipsychotic-like effects in preclinical research. It is a candidate for schizophrenia treatment studies, with activity validated in both in vivo behavioral models and in vitro receptor profiling assays.
Product Specifications
CAS Number
1310426-33-5
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
C (NC) [C@H]1C2=C (C=CS2) CCO1
Molecular Formula
C9H13NOS
Molecular Weight
183.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0007450-01 10 µg
Recombinant Monocyte Chemotactic Protein 4 (MCP4)
Sign In for Pricing
View Details TRV-0007450-02 50 µg
Recombinant Monocyte Chemotactic Protein 4 (MCP4)
Sign In for Pricing
View Details TRV-0007450-03 100 µg
Recombinant Monocyte Chemotactic Protein 4 (MCP4)
Sign In for Pricing
View Details TRV-0007450-04 200 µg
Recombinant Monocyte Chemotactic Protein 4 (MCP4)
Sign In for Pricing
View Details TRV-0007450-05 500 µg
Recombinant Monocyte Chemotactic Protein 4 (MCP4)
Sign In for Pricing
View Details TRV-0007450-06 1 mg
Recombinant Monocyte Chemotactic Protein 4 (MCP4)
Sign In for Pricing
View Details